Details for New Drug Application (NDA): 203259
✉ Email this page to a colleague
The generic ingredient in LAMIVUDINE AND ZIDOVUDINE is lamivudine; zidovudine. There are twenty-nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the lamivudine; zidovudine profile page.
Summary for 203259
Tradename: | LAMIVUDINE AND ZIDOVUDINE |
Applicant: | Hetero Labs Ltd V |
Ingredient: | lamivudine; zidovudine |
Patents: | 0 |
Pharmacology for NDA: 203259
Mechanism of Action | Nucleoside Reverse Transcriptase Inhibitors |
Suppliers and Packaging for NDA: 203259
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LAMIVUDINE AND ZIDOVUDINE | lamivudine; zidovudine | TABLET;ORAL | 203259 | ANDA | Camber Pharmaceuticals, Inc. | 31722-739 | 31722-739-05 | 500 TABLET, FILM COATED in 1 BOTTLE (31722-739-05) |
LAMIVUDINE AND ZIDOVUDINE | lamivudine; zidovudine | TABLET;ORAL | 203259 | ANDA | Camber Pharmaceuticals, Inc. | 31722-739 | 31722-739-31 | 100 TABLET, FILM COATED in 1 BLISTER PACK (31722-739-31) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 150MG;300MG | ||||
Approval Date: | Feb 3, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription